Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation
Authors:
- 26 May 2002
- journal article
- clinical trial
- Published by Wiley in Clinical Endocrinology
- Vol. 56 (5) , 637-641
Abstract
Summary: objective Transdermal testosterone gel treatment is an effective androgen substitution therapy with several advantages over conventional substitution therapies. Whereas side‐effects due to overdosing of hypogonadal patients are unlikely, testosterone gel application without protection may cause severe side‐effects in other subjects (partners, family members) by contamination. Therefore, the risk of testosterone transfer of a newly developed 2·5% testosterone gel preparation was evaluated.design In two clinical randomized open single‐centre studies on healthy male volunteers the percentage of testosterone remaining on the skin after gel application over time (n = 12) and the possibility of a transfer of testosterone to another person (n = 28) was evaluated. In the second study the endogenous testosterone production in the receiving subjects was suppressed by injecting 400 mg norethisterone enanthate (NETE).results After 8 h approximately 60% of testosterone applied to the skin could be recovered. When the skin had been previously washed with water, only about 14% of applied testosterone could be recovered. After intense skin contact with a volunteer who had applied testosterone before on his forearm, no increase in testosterone serum levels could be found in NETE‐suppressed men.conclusion Although considerable amounts of testosterone remain on the intact skin for several hours after evaporation of the alcohol vehicle, contamination of a second, especially female or prepubertal, subject causing side‐effects seems very unlikely.Keywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal menEuropean Journal of Endocrinology, 2002
- Long-Term Pharmacokinetics of Transdermal Testosterone Gel in Hypogonadal MenThe Journal of Clinical Endocrinology & Metabolism, 2000
- Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal functionClinical Endocrinology, 2000
- Long‐term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 yearsClinical Endocrinology, 1999
- Allergy and topical irritation associated with transdermal testosterone administration: A comparison of scrotal and nonscrotal transdermal systems*1Dermatitis®, 1997
- Testosterone Replacement With Transdermal Therapeutic SystemsJAMA, 1989
- Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levelsJAMA, 1989
- SPOUSE-RELATED DRUG SIDE-EFFECTSThe Lancet, 1988
- TRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISMThe Lancet, 1986
- ANDROGENISATION OF FEMALE PARTNERS OF MEN ON MEDROXYPROGESTERONE ACETATE/PERCUTANEOUS TESTOSTERONE CONTRACEPTIONThe Lancet, 1984